Peter Goldschmidt

Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)

April 6, 202212 min read

REYKJAVIK, Iceland & BAD VILBEL, Germany, 06.04.2022 – Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines

Tag: Peter Goldschmidt

Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)

You May Have Missed

European Champions Call on Sports Teams Worldwide to March Forward for Gender Equality

Online Education – Transforming Learning for a Global Generation

5 Random Questions Wins Best Interview Podcast at 2025 Ear Worthy Awards

Bufori Unveils the All-New CS8: A Masterpiece of Power, Precision, and Craftsmanship